Private Equity
Torque Capital Group led a group of investors to buy Brake Parts. Financial terms were not announced. McHenry, Ill.-based Brake Parts makes and supplies global brake system products for the transportation industry. Affinia Group spun off Brake Parts to its shareholders in November 2012.
2 min read · 25 March 2013
Argon Medical Devices, which is backed by RoundTable Healthcare Partners, has agreed to buy the Interventional Products Business of Angiotech Pharmaceuticals. Financial terms weren't announced. The deal is expected to close by April 2013. Interventional Products Business makes and markets disposable and re-usable biopsy products for the diagnosis of cancer, drainage catheter products, and vascular interventional products. Roundtable sold the Interventional Products Business to Angiotech in 2006.
3 min read · 25 March 2013
Theraclone Sciences said Monday it closed $14 million in additional financing. Existing investors -- ARCH Venture Partners, Canaan Partners, MPM Capital, Healthcare Ventures, Alexandria Real Estate Equities, Amgen Ventures, Versant Ventures and Zenyaku Kogyo -- committed $8 million equity. Another $6 million in venture debt was secured through a credit facility with MidCap Financial and Silicon Valley Bank. Seattle-based Theraclone develops novel therapeutic antibodies for the treatment of infectious disease and cancer.
2 min read · 25 March 2013
Christian Parkes has joined Myspace as a VP of Global Marketing, while Joseph Patel was named Vice President of Content + Creative. Most recently, Parkes was Levi's global senior director of marketing. Patel, meanwhile, spent four years as a Senior Producer for Vice Media.
3 min read · 25 March 2013
Ryan Dammeyer has joined Square 1 Bank as a VP for the Midwest region. He will be based in Chicago and responsible for building the bank’s portfolio of clients in the technology and life sciences sectors. Previously, Dammeyer was CFO at Liquidus Marketing.
2 min read · 25 March 2013
Warburg Pincus may be having problems selling Bausch & Lomb, but that hasn't stopped the global PE firm from getting some of its investment back.
2 min read · 25 March 2013
To end your week, we have news that Google is reportedly building a smartwatch, a PE firm devoted cannabis and Punxsutawney Phil gets indicted for lying about Spring.
1 min read · 22 March 2013
Crazy may be hitting the M&A market. Deals in March slowed down but transaction values jumped.
2 min read · 22 March 2013
AXA on Friday announced the sale of a majority stake in its PE arm to an investor group led by Dominique Senequier. AXA Investment Managers will receive Euro 488 million for its holding in AXA Private Equity, a statement says. The deal is expected to close before the end of third quarter. Once the deal closes, AXA PE management and employees will have 40% of voting share capital, while external investors will have 33%. AXA Group will have nearly 27%.
4 min read · 22 March 2013
Today in Second Opinion, there's lots of Google news including their decision to stop printing Frommer's guidebooks and how Google Now has not been submitted to Apple's App store. Also, we have a test to see if your Lululemon yoga pants are bad.
1 min read · 21 March 2013
